drugset / Trial / NCT03236740

OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS

NCT03236740

Phase 4 Completed 101 enrolled S.C.B. Medical College and Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is undertaken to compare the effects of treatment with commonly used OCP containing ethinylestradiol-cyproterone acetate and metformin in women with PCOS. Special attention will be paid to changes in ovarian stromal blood flow by using Color Doppler and they will be correlated with changes in hormonal parameters post-treatment.

Timeline

Start
2017-08-01
Primary completion
2018-03-01
Completion
2018-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg
Comparator cyproterone acetate Small molecule 2 mg Oral
Comparator ethinyl estradiol Small molecule 35 ug Oral